Sunday, March 29, 2020

Strides Pharma Science receives EIR for Bengaluru facility from USFDA

Strides Pharma Science receives EIR for Bengaluru facility from USFDA The inspection by the US Food and Drug Administration (USFDA) was related to specific extended release applications made from the site. Receipt of EIR confirms the successful closure of the inspections, Strides Pharma Science said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3azrdms
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Vedanta, Hindustan Zinc shares fall after metals giant confirms ED visits to offices

Vedanta and Hindustan Zinc shares dipped after the Enforcement Directorate visited some of their offices as part of a FEMA probe. The compan...